Hegyi T
J Clin Monit. 1986 Jan;2(1):53-9. doi: 10.1007/BF01619177.
Hyperbilirubinemia in the newborn infant continues to challenge physicians. Clinical evaluation and treatment have evolved well-established principles over the past decade. This review examines neonatal bilirubin metabolism and focuses on a recently developed clinical diagnostic tool, the transcutaneous bilirubinometer. In spite of some limitations, the transcutaneous bilirubinometer can be best applied as a screening tool to identify healthy full-term infants who require serum bilirubin determination. With proper application, this device can eliminate most invasive diagnostic testing. Optimal use of the instrument requires the relationship between the serum bilirubin concentration and the transcutaneous bilirubinometer index to be determined for each device, institution, and population.
新生儿高胆红素血症仍然是医生面临的挑战。在过去十年中，临床评估和治疗已经形成了完善的原则。这篇综述探讨了新生儿胆红素代谢，并重点介绍了一种最近开发的临床诊断工具——经皮胆红素测定仪。尽管存在一些局限性，但经皮胆红素测定仪作为一种筛查工具，最适合用于识别需要测定血清胆红素的健康足月儿。正确使用该设备可以消除大多数侵入性诊断检测。要优化使用该仪器，需要针对每个设备、机构和人群确定血清胆红素浓度与经皮胆红素测定仪指数之间的关系。
